U.S. Markets close in 6 hrs 27 mins

Weekly CEO Buys Highlight

- By Joy Hu

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Intrexon CEO bought 1,000,000 shares

Intrexon Corp. (XON) CEO and 10% owner Randal J. Kirk bought 1 million shares on Jan. 19 at a price of $12.50. The price of the stock has increased by 14.88% since.

Intrexon is a biotechnology company that develops synthetic biology solutions. It designs, builds and regulates gene programs using its proprietary and complementary technologies. The company has a market cap of $ 1.73 billion. Its shares traded at $14.36 as of January 26.


Total revenue for the three months ended Sept. 30, 2017 was $46.02 million compared to $48.99 million for the year-ago period.

The company announced the closing of its underwritten public offering of common stock on Jan. 19, 2018. Intrexon sold 6.9 million shares of its common stock at a public offering price of $12.50 per share.

OPKO CEO bought 375,000 shares

OPKO Health Inc. (OPK) CEO, Chairman,and 10% owner Phillip Frost bought 375,000 shares during the past week at a price of $4.74.

OPKO is a diversified health care company. Its business includes diagnostics and provision of pharmaceutical products. The company has a market cap of $2.73 billion. Its shares traded at $4.88 as of Jan. 26.

Net loss in thousands for the three months ended Sept. 30, 2017, was $46.44 million compared to $14.98 million for the prior-year period.

Frost bought 100,000 shares of OPKO Health stock on Jan. 22 at a price of $4.4; 100,000 shares on Jan. 23 at a price of $4.76; 100,000 shares on Jan. 24 at a price of $4.89; and 75,000 shares on Jan. 25 at a price of $4.99. The price of the stock has decreased by 2.2% since.

Chemical Financial CEO bought 3,356 shares

Chemical Financial Corp. (CHFC) CEO and President David T. Provost bought 3,356 shares on Jan. 26 at a price of $58.50. The price of the stock has increased by 1.16% since.

Chemical Financial is a financial services provider. The firm conducts its business of commercial banking through its primary subsidiary, Chemical Bank, which offers banking and fiduciary products. The company has a market cap of $4.21 billion. Its shares traded at $59.18 with a price-earnings (P/E) ratio of 28.45 as of Jan. 26.

Net income for the three months ended Sept. 30, 2017, was $40.46 million compared to $11.48 million for the prior-year period.

Director Richard M. Lievense sold 6,298 shares of Chemical Financial stock on Jan. 26 at a price of $57.92. The price of the stock has increased by 2.18% since.

For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

This article first appeared on GuruFocus.